| scholarly article | Q13442814 |
| P50 | author | Julio Montaner | Q1712378 |
| Elizabeth A. Evans | Q60311459 | ||
| Evan Wood | Q85344858 | ||
| Bohdan Nosyk | Q90801622 | ||
| P2093 | author name string | Lei Liu | |
| Viviane D Lima | |||
| Libo Li | |||
| Jeong E Min | |||
| P2860 | cites work | Application and validation of case-finding algorithms for identifying individuals with human immunodeficiency virus from administrative data in British Columbia, Canada | Q28485334 |
| Marginal structural models and causal inference in epidemiology | Q29619287 | ||
| Competing risk regression models for epidemiologic data | Q33459711 | ||
| The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals | Q33505475 | ||
| Cohort profile: Seek and treat for the optimal prevention of HIV/AIDS in British Columbia (STOP HIV/AIDS BC) | Q34001233 | ||
| Use of comorbidity scores for control of confounding in studies using administrative databases | Q34062587 | ||
| Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database | Q34246166 | ||
| Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. | Q34289633 | ||
| Disparities in the burden of HIV/AIDS in Canada | Q34499532 | ||
| Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries | Q35057962 | ||
| Validity of myocardial infarction diagnoses in administrative databases: a systematic review | Q35135179 | ||
| Cardiovascular manifestations of substance abuse: part 2: alcohol, amphetamines, heroin, cannabis, and caffeine | Q35183816 | ||
| Methadone--metabolism, pharmacokinetics and interactions | Q35926494 | ||
| An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research | Q36144599 | ||
| The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. | Q36249104 | ||
| Attributable mortality due to nosocomial infections. A simple and useful application of multistate models. | Q36972423 | ||
| Opiate dependence as an independent and interactive risk factor for arterial stiffness and cardiovascular ageing - a longitudinal study in females | Q37108575 | ||
| Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis | Q37133136 | ||
| Lifetime opiate exposure as an independent and interactive cardiovascular risk factor in males: a cross-sectional clinical study | Q37225383 | ||
| Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies | Q37807466 | ||
| Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved | Q38449652 | ||
| Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain | Q39538201 | ||
| Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. | Q41002448 | ||
| Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment | Q43266430 | ||
| Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. | Q44268615 | ||
| Methadone treatment induces attenuation of cerebrovascular deficits associated with the prolonged abuse of cocaine and heroin | Q44357540 | ||
| Adjusting for time-varying confounding in the subdistribution analysis of a competing risk | Q45063276 | ||
| Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users | Q46084194 | ||
| Multiple ways that drug abuse might influence AIDS progression: clues from a monkey model | Q47245276 | ||
| Retention in methadone maintenance and heroin addicts' risk of death | Q50121455 | ||
| Optimizing treatment outcomes in HIV-infected patients with substance abuse issues | Q50136182 | ||
| Proportional hazards frailty models for recurrent methadone maintenance treatment. | Q51802579 | ||
| Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. | Q53608173 | ||
| Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion | Q72624142 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | anti-retroviral agent | Q50430310 |
| P304 | page(s) | 1157-1165 | |
| P577 | publication date | 2015-06-25 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject Drugs | |
| P478 | volume | 61 |
| Q41993740 | A historical review of HIV prevention and care initiatives in British Columbia, Canada: 1996-2015 |
| Q42709317 | Characterizing Long-Term Health Related Quality of Life Trajectories of Individuals With Opioid Use Disorder |
| Q91863526 | Combined estimation of disease progression and retention on antiretroviral therapy among treated individuals with HIV in the USA: a modelling study |
| Q44334091 | Commentary on Cousins et al. (2016): Accumulating evidence on risk of mortality on and off opioid substitution treatment |
| Q37713805 | Confounding in longitudinal studies in addiction treatment research |
| Q40212094 | Design and implementation of a factorial randomized controlled trial of methadone maintenance therapy and an evidence-based behavioral intervention for incarcerated people living with HIV and opioid dependence in Malaysia. |
| Q89605496 | Do interruptions to the continuity of methadone maintenance treatment in specialist addiction settings increase the risk of drug-related poisoning deaths? A retrospective cohort study |
| Q43494051 | Editorial Commentary: The Impact of Opiate Substitution Therapy and Highly Active Antiretroviral Therapy on Mortality Risk Among People Who Inject Drugs |
| Q89207632 | Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis |
| Q39138996 | Fatal and non-fatal overdose after narcology hospital discharge among Russians living with HIV/AIDS who inject drugs |
| Q89501645 | HIV Treatment Initiation and Retention Among Individuals Initiated on Injectable Opioid Agonist Therapy for Severe Opioid Use Disorder: A Case Series |
| Q36061620 | Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis |
| Q47568945 | Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen among Virally Suppressed Individuals |
| Q38746105 | Initiating HCV treatment with direct acting agents in opioid agonist treatment: When to start for people co-infected with HIV? |
| Q39324890 | Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use. |
| Q30234647 | Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies |
| Q64080932 | Opioid agonist treatment dosage and patient-perceived dosage adequacy, and risk of hepatitis C infection among people who inject drugs |
| Q38851684 | Reducing rates of preventable HIV/AIDS-associated mortality among people living with HIV who inject drugs |
| Q37650905 | Retrospective analysis of antiretroviral therapy uptake and retention of male clients receiving methadone maintenance therapy in two provinces in Vietnam: potential synergy of the two therapies. |
| Q39095973 | The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California |
| Q52318112 | The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom. |
Search more.